These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 18259681)

  • 1. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
    Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
    Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone decreases the inhibitory effect of somatostatin on GH release induced by cigarette smoking in man.
    Coiro V; Volpi R; Stella A; Cataldo S; Giumelli C; Maccanelli F; Araldi A; Chiodera P
    J Neural Transm (Vienna); 2011 Aug; 118(8):1173-5. PubMed ID: 21360300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin, fluid balance and exercise: is exercise-associated hyponatraemia a disorder of arginine vasopressin secretion?
    Hew-Butler T
    Sports Med; 2010 Jun; 40(6):459-79. PubMed ID: 20524712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of naloxone on somatostatin inhibition of arginine vasopressin response to physical exercise in normal men.
    Coiro V; Casti A; Rubino P; Manfredi G; Maffei ML; Volta E; Cataldo S; Melani A; Saccani Jotti G; Chiodera P
    J Neural Transm (Vienna); 2008 Jun; 115(6):803-7. PubMed ID: 18259681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man.
    Coiro V; Casti A; Volta E; Melani A; Maffei ML; Rubino P; Vacca P; Saccani-Jotti G; Volpi R; Chiodera P
    J Neural Transm (Vienna); 2009 Sep; 116(9):1065-9. PubMed ID: 19649691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous opioid mediation of somatostatin inhibition of arginine vasopressin release evoked by insulin-induced hypoglycemia in man.
    Chiodera P; Coiro V
    J Neural Transm Gen Sect; 1991; 83(1-2):121-6. PubMed ID: 1673342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of naloxone on the inhibitory effect of melatonin on the release of arginine-vasopressin induced by physical exercise in man.
    Coiro V; Volpi R; Maffei ML; Volta E; Melani A; Chiodera P
    Regul Pept; 2010 Jun; 162(1-3):1-4. PubMed ID: 20346989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of GABA and opioids in the regulation of the vasopressin response to physical exercise in normal men.
    Chiodera P; Volpi R; Maffei ML; Caiazza A; Caffarri G; Papadia C; Alfano F; Capretti L; Pagani D; Coiro V
    Regul Pept; 1993 Nov; 49(1):57-63. PubMed ID: 8278634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infusion of somatostatin reduces the arginine-vasopressin response to insulin-induced hypoglycemia in man.
    Chiodera P; Gnudi A; Bianconi L; Camellini L; Rossi G; Muzzetto P; Fagnoni F; Schianchi L; Volpi R; Coiro V
    J Endocrinol Invest; 1989 May; 12(5):349-53. PubMed ID: 2570092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.
    Lightman SL; Langdon N; Forsling ML
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1447-9. PubMed ID: 7440706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for endogenous opioid control of vasopressin release in man.
    Lightman SL; Forsling ML
    J Clin Endocrinol Metab; 1980 Mar; 50(3):569-71. PubMed ID: 7358835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man.
    Lightman S; Langdon N; Todd K; Forsling M
    Clin Endocrinol (Oxf); 1982 Apr; 16(4):353-8. PubMed ID: 7094361
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.